Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Archive
Search for this keyword
Advanced search
Close
More
Main menu
Archive
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
Archive
Volume 83, Issue 2
HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Letter
HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis
Online download statistics by month:
Online download statistics by month: September 2023 to April 2025
Abstract
Full
Pdf
Sep 2023
447
447
117
Oct 2023
165
163
64
Nov 2023
126
123
30
Dec 2023
126
125
37
Jan 2024
416
419
138
Feb 2024
199
200
88
Mar 2024
125
123
74
Apr 2024
126
126
59
May 2024
105
103
49
Jun 2024
68
68
31
Jul 2024
56
57
29
Aug 2024
75
76
122
Sep 2024
59
59
24
Oct 2024
106
107
53
Nov 2024
65
67
22
Dec 2024
76
73
33
Jan 2025
51
49
26
Feb 2025
41
41
21
Mar 2025
40
35
19
Apr 2025
35
30
24
Total
2507
2491
1060
Read the full text or download the PDF:
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?